<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Circ Cardiovasc Interv</journal-id><journal-id journal-id-type="iso-abbrev">Circ Cardiovasc Interv</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Circulation. Cardiovascular interventions</journal-title></journal-title-group><issn pub-type="ppub">1941-7640</issn><issn pub-type="epub">1941-7632</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12173781</article-id><article-id pub-id-type="pmcid-ver">PMC12173781.1</article-id><article-id pub-id-type="pmcaid">12173781</article-id><article-id pub-id-type="pmcaiid">12173781</article-id><article-id pub-id-type="manuscript-id">NIHMS2067970</article-id><article-id pub-id-type="pmid">40177778</article-id><article-id pub-id-type="doi">10.1161/CIRCINTERVENTIONS.124.014833</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2067970</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA2067970</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Age-related outcomes after revascularization for chronic limb-threatening ischemia: An analysis of BEST-CLI</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Shah</surname><given-names initials="KB">Khanjan B.</given-names></name><degrees>MD MPH</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Aridi</surname><given-names initials="H">Hanaa</given-names></name><degrees>MD</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dake</surname><given-names initials="MD">Michael D.</given-names></name><degrees>MD</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Doros</surname><given-names initials="G">Gheorghe</given-names></name><degrees>PhD MBA</degrees><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Farber</surname><given-names initials="A">Alik</given-names></name><degrees>MD MBA</degrees><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Menard</surname><given-names initials="MT">Matthew T.</given-names></name><degrees>MD</degrees><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Motaganahalli</surname><given-names initials="R">Raghu</given-names></name><degrees>MD</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chaar</surname><given-names initials="CO">Cassius Ochoa</given-names></name><degrees>MD</degrees><xref rid="A7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rosenfield</surname><given-names initials="K">Kenneth</given-names></name><degrees>MD</degrees><xref rid="A8" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Scali</surname><given-names initials="S">Salvatore</given-names></name><degrees>MD</degrees><xref rid="A9" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shah</surname><given-names initials="SK">Samir K.</given-names></name><degrees>MD MPH</degrees><xref rid="A9" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Strong</surname><given-names initials="MB">Michael B.</given-names></name><degrees>MA</degrees><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Upchurch</surname><given-names initials="GR">Gilbert R.</given-names></name><degrees>MD</degrees><xref rid="A9" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Robinson</surname><given-names initials="W">William</given-names></name><degrees>MD</degrees><xref rid="A10" ref-type="aff">11</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL, USA</aff><aff id="A2"><label>2</label>Division of Vascular Surgery, Indiana University School of Medicine, Indianapolis, IN USA</aff><aff id="A3"><label>3</label>Department of Medical Imaging, University of Arizona Health Sciences, Tucson, AZ, USA</aff><aff id="A4"><label>4</label>Boston University, School of Public Health, Boston, MA USA</aff><aff id="A5"><label>5</label>Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA</aff><aff id="A6"><label>6</label>Division of Vascular and Endovascular Surgery, Brigham and Women&#8217;s Hospital, Harvard Medical School, Boston, MA, USA</aff><aff id="A7"><label>7</label>Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Yale School of Medicine, New Haven, CT, USA</aff><aff id="A8"><label>8</label>Section of Vascular Medicine and Intervention Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA</aff><aff id="A9"><label>9</label>Division of Vascular Surgery and Endovascular Therapy, University of Florida, Gainesville, FL USA</aff><aff id="A10"><label>11</label>Division of Vascular Surgery, Southern Illinois University School of Medicine, Springfield IL, USA</aff><author-notes><corresp id="CR1">Address for correspondence: Khanjan B. Shah, MD MPH, 1329 SW 16<sup>th</sup> St, Suite 5130, Gainesville, Fl 32608, <email>Khanjan.Shah@medicine.ufl.edu</email>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://@KhanjanShahMD" ext-link-type="uri">@KhanjanShahMD</ext-link></corresp></author-notes><pub-date pub-type="ppub"><month>6</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>03</day><month>4</month><year>2025</year></pub-date><volume>18</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">490960</issue-id><fpage>e014833</fpage><lpage>e014833</lpage><pub-history><event event-type="nihms-submitted"><date><day>05</day><month>04</month><year>2025</year></date></event><event event-type="pmc-release"><date><day>01</day><month>06</month><year>2026</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-06-18 11:25:14.837"><day>18</day><month>06</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2067970.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background</title><p id="P1">The impact of age on outcomes following revascularization for CLTI has not been studied in a prospective trial.</p></sec><sec id="S2"><title>Methods</title><p id="P2">1780 patients were grouped into age quartiles (&lt;=55 years, 55 &lt; age &lt;=65 years, 65 &lt; age&lt;=75 years, and &gt;75 years) and by type of revascularization (open bypass or endovascular). The primary outcome was major adverse limb events (MALE) or death, and the secondary outcomes were above-ankle amputation, reintervention, and major adverse cardiovascular events (MACE).</p></sec><sec id="S3"><title>Results</title><p id="P3">Death and MACE was significantly higher in the oldest quartile (&gt;75 years), whereas MALE and above-ankle amputation was highest in the youngest cohort (&lt;=55 years). Younger patients (&lt;=55 years) had the lowest adjusted risk of MALE or all-cause death with open bypass compared to endovascular revascularization. There was no difference in MALE or all-cause death by treatment strategy in patients &gt;75 years of age.</p></sec><sec id="S4"><title>Conclusions</title><p id="P4">Older age was associated with the highest risks of death and MACE and the lowest risks of MALE and above-ankle amputation among patients enrolled in BEST-CLI. Age also had a differential impact by revascularization strategy: youngest patients had the lowest risk of MALE and all-cause death with bypass surgery compared to endovascular revascularization while there was no difference among those &gt;75 years. These data should be used to facilitate shared decision-making in patients with CLTI.</p></sec><sec id="S5"><title>Clinical Trial Registration Information</title><p id="P5"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://biolincc.nhlbi.nih.gov/studies/best_cli/" ext-link-type="uri">https://biolincc.nhlbi.nih.gov/studies/best_cli/</ext-link> (HLB02932424a)</p></sec></abstract><abstract id="ABS2" abstract-type="graphical"><title>Graphical Abstract</title><p id="P6">
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="nihms-2067970-f0001.jpg"/>
</p></abstract><kwd-group><kwd>lower extremity revascularization</kwd><kwd>chronic limb-threatening ischemia</kwd><kwd>peripheral arterial disease</kwd></kwd-group><kwd-group><title>Subject Terms:</title><kwd>Peripheral Vascular Disease</kwd><kwd>Quality and Outcomes</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-exception-type</meta-name><meta-value>EMBARGO</meta-value></custom-meta><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>4</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>no</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>